CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

azenosertibNeutral
AI Analysis

Summary

Zentalis Pharmaceuticals granted non-qualified stock options to purchase 269,000 shares to four newly hired employees as inducement grants under Nasdaq Listing Rule 5635(c)(4).

Importance:1/10
Sentiment:
0.00
inducement grantsstock optionsemployee compensationWEE1 inhibitor
Related Companies

Read the original article

Published by GlobeNewswire Pharma on September 1, 2026 9:15 PM

Read Original